Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0700
-0.0050 (-6.67%)
At close: Mar 20, 2026
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 13.85 million as of March 20, 2026. Its market cap has decreased by -38.44% in one year.
Market Cap
13.85M
Enterprise Value
15.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 13.85M, a decrease of -71.67%. That is a compound annual growth rate of -10.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 13.85M | -21.21% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 27.88M |
| Thiogenesis Therapeutics | 26.95M |
| Lobe Sciences | 18.86M |
| Britannia Life Sciences | 15.41M |
| Rapid Dose Therapeutics | 12.84M |
| Quantum BioPharma | 12.19M |
| PreveCeutical Medical | 11.96M |
| Pharmala Biotech Holdings | 11.44M |